mhurhangee/ep-ind-claims huggingface dataset:
Insect screen for a tilt & turn window consisting of a window frame within which a window pane, hingeable around a horizontal tilting axis, is present and connected to it, in which the insect screen is provided with an accordion-shaped netting, which is provided with a first and second end edge (13a, 13b) in the folding and unfolding direction, and which insect screen comprises two profiles (15, 17) which extend in a U-shape and each of which has two parallel vertical partial profiles (15a, 17a), as well as a horizontal partial profile (15b, 17b) which extends between the two vertical partial profiles (15a, 17a) and is connected to the first ends of the vertical partial profiles, in which the profiles are connected at their second ends by hinges, in which the first of the profiles is connected to the first end edge of the netting and can be attached to the window frame, and the second profile is connected to the second end edge and can detachably be connected to the window pane, and in which the profiles can be switched between a first position in which the netting between the profiles is folded, and a second position in which it is unfolded, characterized in that the insect screen comprises means (25, 29, 31) to make the profiles return automatically from the second to the first position.
A side sill structure for a vehicle, the side sill structure comprising: a side sill (11, 110) having a cavity (11a, 111); a side sill reinforcement (12, 120) which is received in the cavity of the side sill (11, 110); and a battery mounting pipe (20, 200) which is joined to the side sill reinforcement (12, 120), wherein the side sill reinforcement (12, 120) is joined to the side sill (11, 110) as a mounting bolt is fastened to the battery mounting pipe (20, 200). a side sill (11, 110) having a cavity (11a, 111); a side sill reinforcement (12, 120) which is received in the cavity of the side sill (11, 110); and a battery mounting pipe (20, 200) which is joined to the side sill reinforcement (12, 120), wherein the side sill reinforcement (12, 120) is joined to the side sill (11, 110) as a mounting bolt is fastened to the battery mounting pipe (20, 200).
An aerial camera system comprising: at least one camera arranged to capture a plurality of successive images, the at least one camera including at least one respective image sensor, and the field of view of the camera being movable across track relative to a region of the ground; and a stabilisation assembly associated with each camera; the system arranged to control the at least one camera (30 to capture successive images at defined intervals as the field of view of the camera moves across track relative to a region of the ground; characterized in that the stabilisation assembly includes at least two steering mirrors (168, 170) that are controllably movable so as to translate the optical axis of the camera relative to the at least one image sensor in synchronization with image capture so as to effect across track stabilisation of an image on the at least one image sensor during image capture as the field of view of the camera moves across track relative to a region of the ground; and in that the stabilisation assembly comprises a first steering mirror rotated by a first rotational amount and a second steering mirror rotated by a second rotational amount, the first and second rotational amounts being such that the direction of propagation of a light ray directed by the first and second steering mirrors (168, 170) before rotation of the first and second steering mirrors (168, 170) is substantially parallel to the direction of propagation of a light ray directed by the first and second steering mirrors (168, 170)after rotation of the first and second steering mirrors (168, 170). at least one camera arranged to capture a plurality of successive images, the at least one camera including at least one respective image sensor, and the field of view of the camera being movable across track relative to a region of the ground; and a stabilisation assembly associated with each camera; the system arranged to control the at least one camera (30 to capture successive images at defined intervals as the field of view of the camera moves across track relative to a region of the ground; characterized in that the stabilisation assembly includes at least two steering mirrors (168, 170) that are controllably movable so as to translate the optical axis of the camera relative to the at least one image sensor in synchronization with image capture so as to effect across track stabilisation of an image on the at least one image sensor during image capture as the field of view of the camera moves across track relative to a region of the ground; and in that the stabilisation assembly comprises a first steering mirror rotated by a first rotational amount and a second steering mirror rotated by a second rotational amount, the first and second rotational amounts being such that the direction of propagation of a light ray directed by the first and second steering mirrors (168, 170) before rotation of the first and second steering mirrors (168, 170) is substantially parallel to the direction of propagation of a light ray directed by the first and second steering mirrors (168, 170)after rotation of the first and second steering mirrors (168, 170).
Herbal composition comprising Equisetum arvense at a concentration of 3%-67% by weight, Spergularia rubra at a concentration of 2%-38% by weight, Peumus boldus at a concentration of 1.5%-32% by weight, Opuntia ficus indica at a concentration of 1%-20% by weight, Sideritis angustifolia at a concentraiton of 1-20% by weight, Rosmarinus officinalis at a concentration of 1-20% by weight, Cynodon dactylon at a concentration of 1-20% by weight and Melissa officinalis at a concentration of 1-20% by weight for use in the treatment of urolithiasis (kidney stones), and prophylaxis of re-formation of stones after passing them, for the treatment of gout, and for prevention of excessive amount of salts (urates, oxalates, phosphates, carbonates) in kidneys, for the treatment of dysuria phenomenon (pollakiuria, strangury, dysuria, nycturia, low urinary pressure and urinary incontinence), and of urinary and biliary tract spasm, for the treatment of asymptomatic bacteriuria and for the treatment of urinary tract infections (cystitis, urethritis, pyelonephritis).
A security feature for a valuable and/or security product, formed by a pattern that is formed on at least one carrier surface, which has a color progression structure that is formed with a digital printing method from pattern elements arranged in a grid, wherein the color progression structure is produced with at least two luminescence means that exhibit at least two spectrally different luminescences, characterized in that the pattern elements cannot be perceived directly with the human eye without technical aids on account of their dimensions.
A control port assembly (615; 640) for being mounted to a panel of a dialysis unit, wherein the control port assembly comprises control ports (616, 617) arranged for connecting to fluid control ports of a blood pump assembly (13; 1000), the blood pump assembly being mountable on the control port assembly and being part of a blood circuit assembly, wherein the control port assembly further includes a blood circuit assembly engagement device comprising: a pair of retainer members (618a, 618b; 630) pivotably mounted on opposite sides of the control port assembly; a pair of ejector members (622a, 622b; 634) mounted on the opposite sides of the control port assembly; a pair of actuators (626a, 626b; 650) included with the retainer members to allow a user to operate the retainer members and/or ejector members, the actuator movable between a retention position and an ejection position; each retainer member coupled to the corresponding actuator and arranged, with the corresponding actuator in the retention position, to be in contact and retain a corresponding side of the blood pump assembly on the control port assembly, and arranged, with the actuator in the ejection position, to release the blood pump assembly for removal from the control port assembly; and each ejector member coupled to the actuator and arranged, with the corresponding actuator in the retention position, to be in a retracted position, and with the actuator in the ejection position, to be in contact to a corresponding undersurface of the blood pump assembly and to assist in separating the blood pump assembly from the control port assembly. a pair of retainer members (618a, 618b; 630) pivotably mounted on opposite sides of the control port assembly; a pair of ejector members (622a, 622b; 634) mounted on the opposite sides of the control port assembly; a pair of actuators (626a, 626b; 650) included with the retainer members to allow a user to operate the retainer members and/or ejector members, the actuator movable between a retention position and an ejection position; each retainer member coupled to the corresponding actuator and arranged, with the corresponding actuator in the retention position, to be in contact and retain a corresponding side of the blood pump assembly on the control port assembly, and arranged, with the actuator in the ejection position, to release the blood pump assembly for removal from the control port assembly; and each ejector member coupled to the actuator and arranged, with the corresponding actuator in the retention position, to be in a retracted position, and with the actuator in the ejection position, to be in contact to a corresponding undersurface of the blood pump assembly and to assist in separating the blood pump assembly from the control port assembly.
A bio-sensing device suitable for the detection and/or characterization of target DNA and/or RNA bioparticles, the bio-sensing device comprising - a heating element for heating using a power, the heating element being suitable for providing thermal denaturation of target DNA and/or RNA bioparticles - a sample holder adapted for receiving a biocompatible substrate having a functionalized surface which is coated with probe DNA and/or RNA whereto target DNA and/or RNA duplexes can be attached, the sample holder further being adapted for exposing the biocompatible substrate at one side to the heating element - a first temperature sensing element for sensing a temperature at the side where the biocompatible substrate can be exposed to the heating element and a second temperature sensing element for sensing a temperature at the side opposite thereto with respect to the biocompatible substrate, - a processing means programmed for calculating at least one heat transfer resistivity value based on temperature values obtained with the first temperature sensing element and the second temperature sensing element and the power for the heating element, for deriving a characteristic of the target DNA and/or RNA bioparticles from said heat transfer resistivity value. - a heating element for heating using a power, the heating element being suitable for providing thermal denaturation of target DNA and/or RNA bioparticles - a sample holder adapted for receiving a biocompatible substrate having a functionalized surface which is coated with probe DNA and/or RNA whereto target DNA and/or RNA duplexes can be attached, the sample holder further being adapted for exposing the biocompatible substrate at one side to the heating element - a first temperature sensing element for sensing a temperature at the side where the biocompatible substrate can be exposed to the heating element and a second temperature sensing element for sensing a temperature at the side opposite thereto with respect to the biocompatible substrate, - a processing means programmed for calculating at least one heat transfer resistivity value based on temperature values obtained with the first temperature sensing element and the second temperature sensing element and the power for the heating element, for deriving a characteristic of the target DNA and/or RNA bioparticles from said heat transfer resistivity value.
Method for monitoring clock synchronization errors for a network, the method comprising the steps of - sending, by a monitoring node, a synchronization error test message to at least two nodes (3, 4, 5, 6) in the network; - receiving, by the monitoring node, an acknowledgment message from each of the at least two nodes (3, 4, 5, 6), wherein each acknowledgement message comprises a time-stamp representing the local time at which the node (3, 4, 5, 6) has received the synchronization error test message; and - computing, by the monitoring node, synchronization errors based on the received time-stamps. - sending, by a monitoring node, a synchronization error test message to at least two nodes (3, 4, 5, 6) in the network; - receiving, by the monitoring node, an acknowledgment message from each of the at least two nodes (3, 4, 5, 6), wherein each acknowledgement message comprises a time-stamp representing the local time at which the node (3, 4, 5, 6) has received the synchronization error test message; and - computing, by the monitoring node, synchronization errors based on the received time-stamps.
Nestable U-shaped lid and base assembly comprising a separate base and a lid, wherein the base has a general parallelepiped shape formed by a bottom, two lateral walls, a front, a rear part and an upper part, wherein the upper part is open and the front part is partially open, wherein the lid comprises three consecutively aligned parts or sectors, a first part (7.1), a second part (7.2) and a third part (7.3) separated by transverse, scored lines, both the base and the lid having cooperative fastening means arranged on the back of the assembly and on the front of the assembly, wherein: the fastening means arranged on the front of the assembly comprise: - a number of lateral windows close to the front corners and adjacent to the bottom of the base, - on the third part (7.3) of the lid, a number of tabs (7.5) emerging laterally close to the free vertices of the third part (7.3), the fastening means arranged on the back of the assembly comprise: - a foldable flap on the back part of the base, - a window (7.4) on the first part (7.1) of the lid, characterized in that - the window (7.4) is slightly larger in size than the foldable flap defined in the back of the base. - and the foldable flap and the window (7.4) are arranged coincident when the U-shaped lid is nested in the base. the fastening means arranged on the front of the assembly comprise: - a number of lateral windows close to the front corners and adjacent to the bottom of the base, - on the third part (7.3) of the lid, a number of tabs (7.5) emerging laterally close to the free vertices of the third part (7.3), - a number of lateral windows close to the front corners and adjacent to the bottom of the base, - on the third part (7.3) of the lid, a number of tabs (7.5) emerging laterally close to the free vertices of the third part (7.3), the fastening means arranged on the back of the assembly comprise: - a foldable flap on the back part of the base, - a window (7.4) on the first part (7.1) of the lid, - a foldable flap on the back part of the base, - a window (7.4) on the first part (7.1) of the lid, characterized in that - the window (7.4) is slightly larger in size than the foldable flap defined in the back of the base. - and the foldable flap and the window (7.4) are arranged coincident when the U-shaped lid is nested in the base. - the window (7.4) is slightly larger in size than the foldable flap defined in the back of the base. - and the foldable flap and the window (7.4) are arranged coincident when the U-shaped lid is nested in the base.
A photopolymerisable dental composition as a dental covering material for application to and for the isolation and protection of gums and/or teeth during dental treatment, comprising: (a) one or more photopolymerisable monomers selected from the group consisting of acrylates and methacrylates, (b) one or more photoinitiators, (c) one or more molecular weight regulators selected from the group consisting of α-terpinene and γ-terpinene and optionally one or more further additives. (a) one or more photopolymerisable monomers selected from the group consisting of acrylates and methacrylates, (b) one or more photoinitiators, (c) one or more molecular weight regulators selected from the group consisting of α-terpinene and γ-terpinene
Rail vehicle having at least one vehicle antenna of a train protection system, said vehicle antenna being directed toward the track, characterized in that - the carriage body (5a, 5b, 5c) of the rail vehicle and an axle, which is arranged in the region of one end of the rail vehicle, are electrically connected to one another by means of a capacitive connection, and - the at least one vehicle antenna is arranged at a greater distance from the end of the rail vehicle than the axle, which is electrically connected to the carriage body (5a, 5b, 5c). - the carriage body (5a, 5b, 5c) of the rail vehicle and an axle, which is arranged in the region of one end of the rail vehicle, are electrically connected to one another by means of a capacitive connection, and - the at least one vehicle antenna is arranged at a greater distance from the end of the rail vehicle than the axle, which is electrically connected to the carriage body (5a, 5b, 5c).
A method of inducing IDO (indoleamine 2,3-dioxygenase) in a cell culture comprising ex-vivo treating antigen presenting cells obtained from a mammal with an agent which induces IDO in said antigen presenting cells in the presence of a drug or an epitope containing fragment thereof, wherein the drug is Factor VIII or Factor IX and wherein the agent which induces IDO is selected from zebularine, 2'-deoxyzebularine, 5-fluoro-zebularine, 5-fluoro-2'-deoxyzebularine, 5-chloro-zebularine, 5-chloro-2'-deoxyzebularine, 5-bromo-zebularine, 5-bromo-2'-deoxyzebularine, 5-iodo-zebularine, 5-iodo-2'-deoxyzebularine, 5-methylpyrimidin-2-one, 5-Me-2'-deoxyzebularine, or mono, di or tri phosphates thereof or salts thereof, 5-methylcytidine, azacytidine or deoxyazacytidine, histone deacetylase inhibitors, vitamin D3 analogues, interferons, toll like receptor ligands, gonadotropin receptor signalling hormones, prostaglandin E2, soluble CTLA4 conjugates, TGF-beta, IL-10 and glucocorticoids.
Device for checking a functionality of a first resistor of a battery system, wherein the device comprises a constant current source, a switch, a second resistor, a first means and a second means, wherein the first means is configured to detect a first voltage value as a voltage drop across the first resistor, to determine therefrom a first current value and to transfer the first current value to the second means with the aid of a connection, wherein the first means comprises an amplifier having a dynamic first gain factor, wherein the second means is configured to detect a second voltage value as a voltage drop across the second resistor and to determine therefrom a second current value, wherein the second means is configured to compare the first current value and the second current value, wherein the second means is configured to generate a first signal if the first current value and the second current value are substantially equal, wherein the first signal represents the functionality of the first resistor, wherein the device comprises a third resistor, wherein the first means is configured to detect a third voltage value as a voltage drop across the third resistor, to determine therefrom a third current value and to transfer the third current value to the second means with the aid of the connection, and the second means generates the first signal if the first current value, the second current value and the third current value are substantially equal, wherein the first means is configured to determine a second gain factor as a function of the first current value and the third current value and to compare it with the dynamic first gain factor and to generate a second signal if the dynamic first gain factor and the second gain factor substantially match.
A wavelength-selective transmissive glass having a light transmittance T more than 315 nm and 400 nm or less at a wavelength of more than 315 nm and 400 nm or less represented by the formula shown below of 1% or more in terms of a plate thickness of 6 mm and a light transmittance T 315 nm or less at a wavelength of 315 nm or less represented by the formula shown below of 60% or less in terms of a plate thickness of 6 mm: T more than 315 nm and 400 nm or less = ∑ k = more than 315 400 A k × T k / ∑ k = more than 315 400 A k T 315 nm or less = ∑ k = 300 315 A k × T k / ∑ k = 300 400 A k. wherein A k is a weighting factor at a wavelength k (nm) for calculating T (light transmittance) defined in ISO-9050:2003, and T k is a transmittance at the wavelength k (nm) in terms of a plate thickness of 6 mm, wherein the wavelength-selective transmissive glass comprises, as represented by mass% based on oxides, SiO 2: 60 to 80%, Al 2 O 3: 0 to 7%, MgO: 0 to 10%, CaO: 4 to 20%, Na 2 O: 7 to 20%, and K 2 O: 0 to 10%, as a glass matrix composition, and wherein as represented by mass% based on oxides, a total iron content represented by Fe 2 O 3 is 0.04 to 0.15%, CeO 2 is 0.35 to 0.45%, TiO 2 is 0 to 0.2%, SnO 2 is 0 to 0.2%, CeO 2 +3×TiO 2 +6×SnO 2 is 0.41 to 0.5, and a value of Fe-Redox is 25 to 65%, wherein the value Fe-Redox is the proportion of Fe <2+> content in terms of Fe 2 O 3 to the total iron content in terms of Fe 2 O 3. wherein A k is a weighting factor at a wavelength k (nm) for calculating T (light transmittance) defined in ISO-9050:2003, and T k is a transmittance at the wavelength k (nm) in terms of a plate thickness of 6 mm, wherein the wavelength-selective transmissive glass comprises, as represented by mass% based on oxides, SiO 2: 60 to 80%, Al 2 O 3: 0 to 7%, MgO: 0 to 10%, CaO: 4 to 20%, Na 2 O: 7 to 20%, and K 2 O: 0 to 10%, as a glass matrix composition, and wherein as represented by mass% based on oxides, a total iron content represented by Fe 2 O 3 is 0.04 to 0.15%, CeO 2 is 0.35 to 0.45%, TiO 2 is 0 to 0.2%, SnO 2 is 0 to 0.2%, CeO 2 +3×TiO 2 +6×SnO 2 is 0.41 to 0.5, and a value of Fe-Redox is 25 to 65%, wherein the value Fe-Redox is the proportion of Fe <2+> content in terms of Fe 2 O 3 to the total iron content in terms of Fe 2 O 3.